用户名: 密   码:
注册 | 忘记密码?
药品详细

Anileridine(阿尼利定)

化学结构式图
中文名
阿尼利定
英文名
Anileridine
分子式
C22H28N2O2
化学名
ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate
分子量
Average: 352.4699
Monoisotopic: 352.21507815
CAS号
144-14-9
ATC分类
N01A 未知
药物类型
small molecule
阶段
illicit, approved
商品名
同义名
基本介绍

Anileridine is a synthetic opioid and strong analgesic medication. It is a narcotic pain reliever used to treat moderate to severe pain. Narcotic analgesics act in the central nervous system (CNS) to relieve pain. Some of their side effects are also caused by actions in the CNS.

生产厂家
  • Merck and co inc
封装厂家
参考
Synthesis Reference Not Available
General Reference Not Available
剂型
规格
化合物类型
Type small molecule
Classes
  • Phenylpiperidines
Substructures
  • Carbonyl Compounds
  • Carboxylic Acids and Derivatives
  • Acetates
  • Phenylacetates
  • Aliphatic and Aryl Amines
  • Ethers
  • Benzene and Derivatives
  • Phenylpiperidines
  • Phenethylamines
  • Heterocyclic compounds
  • Aromatic compounds
  • Phenylpropylamines
  • Anilines
  • Piperidines
适应症
药理
Indication For treatment and management of pain (systemic) and for use as an anesthesia adjunct.
Pharmacodynamics Anileridine, a potent analgesic, is an analog of pethidine. Anileridine is useful for the relief of moderate to severe pain. It may also be used as an analgesic adjunct in general anesthesia in the same manner as meperidine to reduce the amount of anesthetic needed, to facilitate relaxation, and to reduce laryngospasm. In addition, anileridine exerts mild antihistaminic, spasmolytic and antitussive effects. Anileridine's main pharmacologic action is exerted on the CNS. Respiratory depression, when it occurs, is of shorter duration than that seen with morphine or meperidine when equipotent analgesic doses are used.
Mechanism of action Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Opioids such as anileridine close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability.
Absorption Anileridine is absorbed by all routes of administration.
Volume of distribution Not Available
Protein binding > 95%
Metabolism
Hepatic
Route of elimination Not Available
Half life Not Available
Clearance Not Available
Toxicity Symptoms of overexposure include dizziness, perspiration, a feeling of warmth, dry mouth, visual difficulty, itching, euphoria, restlessness, nervousness and excitement have been reported.
Affected organisms
  • Humans and other mammals
Pathways Not Available
理化性质
Properties
State solid
Experimental Properties
Property Value Source
melting point 83 °C PhysProp
logP 3.7 Not Available
Predicted Properties
Property Value Source
water solubility 1.24e-02 g/l ALOGPS
logP 4.05 ALOGPS
logP 3.64 ChemAxon
logS -4.5 ALOGPS
pKa (strongest basic) 8.88 ChemAxon
physiological charge 1 ChemAxon
hydrogen acceptor count 3 ChemAxon
hydrogen donor count 1 ChemAxon
polar surface area 55.56 ChemAxon
rotatable bond count 7 ChemAxon
refractivity 106.55 ChemAxon
polarizability 40.98 ChemAxon
药物相互作用
食物相互作用
  • Take without regard to meals.

返回 | 收藏